{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:54:41Z","timestamp":1762253681995,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ecl.2020.12.003","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T10:49:35Z","timestamp":1611830975000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hyperandrogenic Anovulation"],"prefix":"10.1016","volume":"50","author":[{"given":"Margaret E.","family":"Wierman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ecl.2020.12.003_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijwd.2017.10.006","article-title":"A\u00a0review of diagnosis and treatment of acne in adult female patients","volume":"4","author":"Tan","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"10.1016\/j.ecl.2020.12.003_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.12149","article-title":"Epidemiology of acne vulgaris","volume":"168","author":"Bhate","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.ecl.2020.12.003_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2007.06.045","article-title":"The prevalence of acne in adults 20 years and older","volume":"58","author":"Collier","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ecl.2020.12.003_bib4","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Martin","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"24","key":"10.1016\/j.ecl.2020.12.003_bib5","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1056\/NEJMcp033496","article-title":"Clinical practice. Hirsutism","volume":"353","author":"Rosenfield","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2020.12.003_bib6","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2020.12.003_bib7","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.ajog.2004.06.064","article-title":"The prevalence of androgen excess among patients with minimal unwanted hair growth","volume":"191","author":"Souter","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.003_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11102-008-0109-3","article-title":"Female hypogonadism: evaluation of the hypothalamic-pituitary-ovarian axis","volume":"11","author":"Rothman","year":"2008","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.003_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.ecl.2020.12.003_bib10","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2020.12.003_bib11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.tem.2018.08.005","article-title":"New perspectives on the pathogenesis of PCOS: neuroendocrine origins","volume":"29","author":"Walters","year":"2018","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2020.12.003_bib12","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/jc.2017-02426","article-title":"Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women","volume":"103","author":"Elhassan","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2020.12.003_bib13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MOP.0000000000000778","article-title":"The diagnosis and treatment of PCOS in adolescents: an update","volume":"31","author":"Witchel","year":"2019","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.ecl.2020.12.003_bib14","doi-asserted-by":"crossref","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","journal-title":"PloS Med"},{"key":"10.1016\/j.ecl.2020.12.003_bib15","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.003_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2265.2006.02740.x","article-title":"Congenital adrenal hyperplasia and P450 oxidoreductase deficiency","volume":"66","author":"Krone","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.ecl.2020.12.003_bib17","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"95","author":"Speiser","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2020.12.003_bib18","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev"},{"issue":"Suppl 5","key":"10.1016\/j.ecl.2020.12.003_bib19","first-page":"158","article-title":"Adult consequences of congenital adrenal hyperplasia","volume":"68","author":"Arlt","year":"2007","journal-title":"Horm Res"},{"issue":"12","key":"10.1016\/j.ecl.2020.12.003_bib20","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1210\/jc.2013-2375","article-title":"Clinical review: lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause","volume":"98","author":"Welt","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9996","key":"10.1016\/j.ecl.2020.12.003_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ecl.2020.12.003_bib22","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s's syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.003_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.12.003_bib24","series-title":"Endotext [Internet]","article-title":"Prolactinoma Management. [Updated 2018 Sep 30]","author":"Molitch","year":"2000"},{"issue":"2","key":"10.1016\/j.ecl.2020.12.003_bib25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2265.2011.04040.x","article-title":"How should postmenopausal androgen excess be evaluated?","volume":"75","author":"Rothman","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.ecl.2020.12.003_bib26","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/09513590.2019.1599855","article-title":"The clinical features and reproductive prognosis of ovarian neoplasms with hyperandrogenemia: a retrospective analysis of 33 cases","volume":"35","author":"Shu","year":"2019","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2020.12.003_bib27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/dta.2763","article-title":"Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents","volume":"12","author":"Borjesson","year":"2020","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.ecl.2020.12.003_bib28","article-title":"The anabolic androgenic steroid treatment gap: a national study of substance use disorder treatment","volume":"14","author":"Havnes","year":"2020","journal-title":"Subst Abuse"},{"issue":"10","key":"10.1016\/j.ecl.2020.12.003_bib29","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1210\/jc.2014-2260","article-title":"Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline","volume":"99","author":"Wierman","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2020.12.003_bib30","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1210\/jc.2006-1121","article-title":"Androgen therapy in women: an Endocrine Society Clinical Practice guideline","volume":"91","author":"Wierman","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2020.12.003_bib31","doi-asserted-by":"crossref","DOI":"10.1210\/jcem-71-5-1081","article-title":"Clinical review 15: management of ovulatory disorders with pulsatile gonadotropin-releasing hormone","volume":"71","author":"Martin","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2020.12.003_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.fertnstert.2017.08.037","article-title":"Value of selective venous catheterization in the diagnosis of hyperandrogenism","volume":"108","author":"Hickman","year":"2017","journal-title":"Fertil Steril"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852920300918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852920300918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:46:06Z","timestamp":1760175966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852920300918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0889852920300918"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2020.12.003","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperandrogenic Anovulation","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2020.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}